Side Effects of COVID-19 Vaccines Primer Doses: Experience of Saudi Healthcare Workers Participating in CoVaST-SA

Investor logo
Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

RIAD Abanoub ALSAAD S. S. ALMURIKHI A. A. ALZAHRANI F. A. ALGHAMDI A. M. ALZAID E. H. KLUGAR Miloslav

Year of publication 2022
Type Article in Periodical
Magazine / Source Vaccines
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.mdpi.com/2076-393X/10/12/2137
Doi http://dx.doi.org/10.3390/vaccines10122137
Keywords CoVaST; COVID-19 vaccines; drug-related side effects and adverse reactions; health personnel; Saudi Arabia
Attached files
Description Background: Side effects emerging after COVID-19 vaccines may adversely impact public confidence in vaccines. Therefore, this study was designed to explore the short-term side effects of COVID-19 vaccines as a part of the COVID-19 Vaccines Safety Tracking (CoVaST) study. Methods: A cross-sectional survey-based study was carried out to collect data from healthcare workers (HCWs) in Saudi Arabia. The study was initiated between June and December 2021. A validated questionnaire was used in this study consisting of four categories, including demographic characteristics and medical anamnesis of the participants, COVID-19-associated anamnesis, and side effects of vaccine uptake. Results: The study included 1039 participants, of which 70.2% were females, and their median age was 34. About 82.9% and 52.3% of the participants reported a minimum of both one local and systemic side effect, respectively. Females, young participants (?34 years old), and non-obese participants had more potential to disclose post-vaccination side effects than their counterparts. Heterologous schedules and viral vector-based vaccines were linked with a greater rate of systemic side effects, whereas homologous vaccination schedules and mRNA-based vaccines were linked with a greater rate of local side effects. Conclusion: Future studies on COVID-19 vaccines should focus on the role of BMI, previous infection, and vaccination schedule in terms of vaccine safety and reactogenicity.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.